Purification notesab53510 purity is determined by SDS-PAGE, showing that the IgY(deltaFc) constitute was 81.2% of total protein, and the IgY and IgY(deltaFc) constitute was 83.8% of total protein.
Adsorption is performed by BSA coupling column.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesELISA: titer 1/22000, defined as the dilution of antibody(1mg/ml)sufficient to give a change in absorbance of 1.0 at 450nm.
ID: Use at an assay dependent dilution.
Ie: Use at an assay dependent dilution.
WB: Use at an assay dependent dilution.
TIA: Use at an assay dependent dilution.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceDigoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat).
References for Anti-Digoxin antibody (ab53510)
has not yet been referenced specifically in any publications.
Publishing research using ab53510? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"